RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Rezolute Stock

Rezolute Revenue 2025

Rezolute Revenue

0 USD

Ticker

RZLT

ISIN

US76200L3096

In 2025, Rezolute's sales reached 0 USD, a 0% difference from the 0 USD sales recorded in the previous year.

The Rezolute Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2030e550.2-0,41
2029e370.2-0,61
2028e194.76-1,16
2027e45.59-4,96
2026e7.42-30,48
2025e--
2024e--
2023--
2022--
2021--
2020--
2019--
2018--
2017--
2016--
2015--
2014--
2013--
2012--
2011--
2010--

Rezolute Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Rezolute, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Rezolute from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Rezolute’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Rezolute. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Rezolute’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Rezolute’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Rezolute’s growth potential.

Rezolute Revenue, EBIT and net profit per share

DateRezolute RevenueRezolute EBITRezolute Net Income
2030e550.2 M undefined0 undefined208.03 M undefined
2029e370.2 M undefined189.27 M undefined144.32 M undefined
2028e194.76 M undefined43.66 M undefined43.26 M undefined
2027e45.59 M undefined-66.39 M undefined-48.58 M undefined
2026e7.42 M undefined-95.31 M undefined-70.52 M undefined
2025e0 undefined-73.37 M undefined-55.67 M undefined
2024e0 undefined-66.26 M undefined-70.66 M undefined
20230 undefined-55.99 M undefined-51.79 M undefined
20220 undefined-41.84 M undefined-41.06 M undefined
20210 undefined-22.9 M undefined-20.9 M undefined
20200 undefined-20.52 M undefined-20.33 M undefined
20190 undefined-25.9 M undefined-32.72 M undefined
20180 undefined-26.38 M undefined-29.86 M undefined
20170 undefined-20.32 M undefined-23.68 M undefined
20160 undefined-14.95 M undefined-20.91 M undefined
20150 undefined-10.7 M undefined-11.36 M undefined
20140 undefined-5.18 M undefined-9.73 M undefined
20130 undefined-6.11 M undefined-6.73 M undefined
20120 undefined-50,000 undefined-50,000 undefined
20110 undefined-40,000 undefined-40,000 undefined
20100 undefined0 undefined0 undefined

Rezolute stock margins

The Rezolute margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Rezolute. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Rezolute.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Rezolute's sales revenue. A higher gross margin percentage indicates that the Rezolute retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Rezolute's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Rezolute's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Rezolute's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Rezolute. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Rezolute's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Rezolute Margin History

Rezolute Gross marginRezolute Profit marginRezolute EBIT marginRezolute Profit margin
2030e0 %0 %37.81 %
2029e0 %51.13 %38.98 %
2028e0 %22.42 %22.21 %
2027e0 %-145.61 %-106.55 %
2026e0 %-1,285.02 %-950.85 %
2025e0 %0 %0 %
2024e0 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %
20100 %0 %0 %

Rezolute Aktienanalyse

What does Rezolute do?

Rezolute Inc. is a bio-pharmaceutical company that was founded in 2010 in California. The company specializes in the research and development of innovative therapies for the treatment of rare metabolic and endocrine diseases. The business model of Rezolute is to develop innovative solutions and treatment approaches for diseases that currently have insufficient treatment options. The company is actively working to expand its product pipeline and explore new treatment methods in order to give hope and prospects for a better quality of life to suffering patients. Rezolute is active in three main areas: diabetes and metabolic diseases, diseases of the endocrine system, and protein-based therapy platforms. Each of these areas is of great importance in combating rare diseases that are often overlooked by the pharmaceutical industry. The diabetes and metabolic diseases category is the core business of Rezolute Inc. The company strives to develop innovative therapies for the treatment of diabetes itself and its comorbidities. This includes diseases of the cardiovascular system and kidney diseases, which are common among diabetes patients. In the category of endocrine diseases, the company is working on the development of targeted therapies for the treatment of diseases such as hypothyroidism (an underactive thyroid) and hypopituitarism (a deficiency of hormones produced by the pituitary gland). These diseases are often overlooked by the pharmaceutical industry as they occur less frequently compared to other diseases. The protein-based therapy platforms are technologically advanced and have the potential to offer new treatment options. Rezolute utilizes its own proprietary technologies for the development of immunoglobulins and drugs that specifically target certain molecules. The company is also researching compounds that can influence the immune system to combat inflammation and autoimmune diseases. Rezolute currently has several therapy options in development. The company is working on RZ358, an oral insulin formulation for the treatment of diabetes; RZ402, a drug for the treatment of pancreatitis (inflammation of the pancreas); and RZ402, a drug for the treatment of pancreatitis (inflammation of the pancreas). The company has also obtained orphan drug status to develop RZ358, its innovative therapy for the treatment of Congenital Hyperinsulinism (CHI), a rare, congenital endocrine disorder. Rezolute has established itself as an important player in the global bio-pharmaceutical market. The company is committed to improving the lives of patients suffering from rare diseases by developing innovative treatment options. With a dedicated team of scientists and researchers, the company strives to push the boundaries of science and develop the next generation of innovative therapies that have the potential to improve the lives of patients. Rezolute ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Rezolute's Sales Figures

The sales figures of Rezolute originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Rezolute’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Rezolute's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Rezolute’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Rezolute stock

How much revenue did Rezolute generate this year?

Rezolute has achieved a revenue of 0 USD this year.

How much was the turnover of the company Rezolute compared to the previous year?

The revenue of Rezolute has increased by 0% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Rezolute?

The revenue of Rezolute is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Rezolute measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Rezolute so important for investors?

The revenue of Rezolute is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Rezolute pay?

Over the past 12 months, Rezolute paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Rezolute is expected to pay a dividend of 0 USD.

What is the dividend yield of Rezolute?

The current dividend yield of Rezolute is .

When does Rezolute pay dividends?

Rezolute pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Rezolute?

Rezolute paid dividends every year for the past 0 years.

What is the dividend of Rezolute?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Rezolute located?

Rezolute is assigned to the 'Health' sector.

Wann musste ich die Aktien von Rezolute kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rezolute from 2/26/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/26/2025.

When did Rezolute pay the last dividend?

The last dividend was paid out on 2/26/2025.

What was the dividend of Rezolute in the year 2024?

In the year 2024, Rezolute distributed 0 USD as dividends.

In which currency does Rezolute pay out the dividend?

The dividends of Rezolute are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Rezolute

Our stock analysis for Rezolute Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rezolute Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.